Here we report that although the collagen network architecture is changed, neither the quantitative or qualitative properties of glycosmaminoglycans are affected by fibromodulin-deficiency, in a syngeneic experimental model of carcinoma. The gene discussed is FMOD; the disease is carcinoma.